Actavis Recalls Vancomycin Capsules Due to Subpotency
Actavis recalls 6,913 packages of Vancomycin Hydrochloride Capsules (250 mg) due to subpotent drug issues. Check lot numbers and expiry dates.
Use caution until it’s fixed
Subpotent Drug.
Contact the company
What happened, in plain English
Actavis Inc is recalling Vancomycin Hydrochloride Capsules, USP, 250 mg because the drug may be subpotent. The affected product consists of 20 capsules on 2 x 10 capsule blister cards. This recall involves 6,913 packages distributed nationwide in the U.S. Read more at govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20.
Source Summary by GovInfoNow · govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1386-2014
Cite this page
“Actavis Recalls Vancomycin Capsules Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46037-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-20. Based on FDA recall #D-1386-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1386-2014%22&limit=1).
Why it’s dangerous
The hazard is described as a 'Subpotent Drug,' meaning the capsules may contain less active ingredient than labeled. This can result in inadequate treatment for bacterial infections, potentially allowing the infection to persist or worsen because the medication is not working as intended.
Who’s affected
Patients who have been prescribed Vancomycin Hydrochloride Capsules, USP, 250 mg by a healthcare provider are likely affected. Individuals who purchased or were dispensed this specific medication between its manufacture and the recall date are at risk of receiving subpotent doses.
How to tell if you have this one
Look for Vancomycin Hydrochloride Capsules, USP, 250 mg packaged as 20 capsules on 2 x 10 capsule blister cards. Check for NDC 0591-3561-15 and Lot # 3100135 with an expiry date of 05/2014. The product was manufactured by Patheon Pharmaceuticals Inc. for Watson Pharma Inc.
- Brand
Actavis- Category
Drug
What to do — step by step
Contact Your Pharmacist
Reach out to the pharmacy where you filled your prescription to determine if your specific lot is part of this recall.
Do Not Stop Medication Without Advice
Consult your healthcare provider before making any changes to your medication regimen, as they can advise on alternative treatments or replacements.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1386-2014 (May 16, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1386-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.